Phospho-Met (Tyr1349) Antibody 3121S from Cell Signaling Technology

Product Specs
ItemPhospho-Met (Tyr1349) Antibody
CompanyCell Signaling Technology
Price Pricing Info Supplier Page View Company Product Page
Catalog Number3121S
Quantity100 µl
ApplicationsW, IP
ReactivityH, M, R
TargetMet (Tyr1349) phosphate
ModificationsMet (Tyr1349) phosphate
HostRabbit
NCBI Gene AliasesAUTS9, DA11, DFNB97, HGFR, RCCP2, c-Met
NCBI Full Gene NameMET proto-oncogene, receptor tyrosine kinase
ClonalityPolyclonal
Research AreaRTK
Molecular Weight145

Add to Compare List

Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

Company Profile

Website: http://www.cellsignal.com/

Website: Technical Support

(1) SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric CancerCellsOctober 18, 2023Katia De Marco, Martina Lepore Signorile, Elisabetta Di Nicola, Paola Sanese, Candida Fasano, Giovanna Forte, Vittoria Disciglio, Antonino Pantaleo, Greta Varchi, Alberto Del Rio, et al.MA, USA), anti-AKT (#9272, Cell Signaling Technology, Danvers, MA, USA), anti-phospho-MET (Tyr1349) (#3121, Cell Signaling Technology, Danvers, MA, USA), anti-MET (#8198, Cell Signaling Technology, Danvers,

(2) Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant MelanomaVeterinary sciencesMarch 26, 2023Koo K, Wuenschmann A, Rendahl A, Song KY, Forster C, Wolf-Ringwall A, Borgatti A, Giubellino A.Danvers, MA, USA; Tyr1234/1235, Cat. No.3077), Phospho-MET (Cell Signaling Technology, Tyr1349, Cat. No. 3121), and β-actin (Cell Signaling Technology, Cat. No. 3700) were performed according to the manufacturer’s

(3) Designing Organoid Models to Monitor Cancer Progression, Plasticity and Resistance: The Right Set Up for the Right QuestionCancersJuly 22, 2022Doffe F, Bonini F, Lakis E, Terry S, Chouaib S, Savagner P.BioLegend), mucin1 (Rabbit Abcam), E-cadherin (13-1700, Zymed, San Diego, CA, USA), Desmogleins (SAD-3121, Labgen) and PCNA1 (2586S CST, caspase 3 (9662, CST). 2.10. Microscopy For imaging, pictures and movies,

(4) Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinasesNeoplasiaJune 1, 2022Diana Sofía Acevedo et al.pY1234/1235-MET (Cell Signaling Technology, cat no.3077S), pY1349-MET (Cell Signaling Technology, cat no.3121S), MET, Hexokinase II (HK2) (Cell Signaling Technology, cat no.2867), PKM1/2 (Cell Signaling Technology,

(5) Identifying novel SMYD3 interactors on the trail of cancer hallmarksComputational and Structural Biotechnology JournalApril 11, 2022Candida Fasano, Martina Lepore Signorile, Katia De Marco, Giovanna Forte, Paola Sanese, Valentina Grossi, Cristiano SimoneCell Signaling), BLM (#2742, Rabbit, Cell Signaling), MET (#8198, Rabbit, Cell Signaling), phospho-MET (#3121, Rabbit, Cell Signaling), p130 (#610262, Mouse, BD Biosciences), RPB1 (Ab76123, Anti-RNA polymerase II RPB1

(6) MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive TumourigenesisCancers (Basel)March 8, 2022Daniel Lu, Amy Nagelberg, Justine LM Chow, Yankuan T Chen, Quentin Michalchuk, Romel Somwar, William W. Lockwoodfrom Cell Signaling Technology (Danvers, MA, USA): MET (8198S), p-MET Tyr1234 (3077S), p-MET Tyr1349 (3121S), AKT (4691S)), p-AKT Ser473 (4060L), p44/42 MAPK (137F5), p-p44/42 MAPK Thr202/Tyr204 (9101S), MEK1/2

(7) Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypassScientific ReportsDecember 1, 2021Mark Borris D. Aldonza et al.Primary antibodies used were: pEGFR(Y1068) (ab5644, abcam), EGFR (ab52894, abcam), pMET(Tyr1349) (#3121, CST), MET (#8198, CST) pAKT(Ser473) (#9271, CST), AKT (#9272, CST), pERK1/2(Thr202/Tyr204) (#4370,

(8) Knockout of mafba Causes Inner-Ear Developmental Defects in Zebrafish via the Impairment of Proliferation and Differentiation of Ionocyte Progenitor CellsBiomedicinesNovember 16, 2021Chen X, Huang Y, Gao P, Lv Y, Jia D, Sun K, Han Y, Hu H, Tang Z, Ren X, et al.primary antibodies were used in this study: anti-Mafb (PA5-40756, Thermo Scientific; 1:500), anti-p53 (3121, Daian; 1:1000), anti-γH2AX (9178s, CST; 1:1000), anti-GAPDH (60004, Proteintech; 1:1000), anti-CDK2

(9) CDCP1 promotes compensatory renal growth by integrating Src and Met signalingLife science allianceApril 1, 2021Kajiwara K, Yamano S, Aoki K, Okuzaki D, Matsumoto K, Okada M.(9132), anti-STAT3 pY705 (9145), anti-myc-tag (2276), anti-Met pY1234/1235 (3077), anti-Met pY1349 (3121) anti-Met (3127, clone 25H2), and anti-Met (8198) antibodies were all purchased from Cell Signaling Technologies

(10) KRAS Controls Pancreatic Cancer Cell Lipid Metabolism and Invasive Potential through the Lipase HSLCancer researchNovember 15, 2020Rozeveld CN, Johnson KM, Zhang L, Razidlo GL.(610182, BD Biosciences), N-Cadherin (610921, BD Bioscience), CPT1 (12252, Cell Signaling), PLIN-2 (3121, LSBio), PLIN-3 (10694, Proteintech), PLIN-5 (46215, Invitrogen), Actin (A2066, Sigma), and GAPDH (5174,

(11) Co-occurring Alterations in the RAS–MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung CancerClinical Cancer ResearchJanuary 15, 2020Julia K. Rotow et al.Cell Signaling Technology (Danvers, MA, USA) and were used at a dilution of 1:1000: MET (#3148), p-MET Y1349 (#3121), pMEK S217/221 (#9121), ERK1/2 (#3493), p-ERK1/2 T202/Y204 (#9106), HSP90 (#4874), PARP (#9546), NF1

(12) Identification of Sex-Specific Transcriptome Responses to Polychlorinated Biphenyls (PCBs)Scientific ReportsDecember 1, 2019Almudena Espín-Pérez et al.cells,180,2,0,127 Females,CD8T,118,0,0,0 Females,CD8T,138,0,0,1 Females,CD8T,153,0,0,5 Females,CD8T,156,0,0,4 Females,CD8T,170,0,0,4 Females,CD8T,180,0,0,3 Females,CD4T,118,0,0,3121 Females,CD4T,138,0,0,2755 Females,CD4T,153,0,0,3004 Females,CD4T,156,0,0,3586 Females,CD4T,170,0,0,4326 Females,CD4T,180,0,0,5315 Females,NK,118,0,0,2 Females,NK,138,0,0,1 Females,NK,153,0,0,1 Females,NK,156,0,0,73 Females,NK,170,0,0,21 Females,NK,180,0,0,1 Females,Mono,118,0,0,723 Females,Mono,138,0,0,7445 Females,Mono,153,1,0,8373 Females,Mono,156,1,1,10120 Females,Mono,170,2,0,9352 Females,Mono,180,2,0,7944 Males,B

(13) Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapiesNature communicationsNovember 14, 2019Montero J, Gstalder C, Kim DJ, Sadowicz D, Miles W, Manos M, Cidado JR, Paul Secrist J, Tron AE, Flaherty K, et al.rabbit anti-phospho-ALK (CST, #3341), rabbit anti-ALK (CST, #3633), rabbit anti-phospho-MET Y1349 (CST, #3121), rabbit anti-MET (CST, #8198), rabbit anti-phospho-ERK (CST, #9101), rabbit anti-ERK (CST, #4695),

(14) The potassium channel KCNJ13 is essential for smooth muscle cytoskeletal organization during mouse tracheal tubulogenesisNature communicationsJuly 19, 2018Yin W, Kim HT, Wang S, Gunawan F, Wang L, Kishimoto K, Zhong H, Roman D, Preussner J, Guenther S, et al.

(15) Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitorsOncotargetJune 5, 2018Mekki MS, Mougel A, Vinchent A, Paquet C, Copin MC, Leroy C, Kherrouche Z, Bonte JP, Melnyk O, Vicogne J, et al.(Tyr 1234/1235, #3077 – Cell Signaling®; Tyr 1003, #44-882 Biosource™ Life Technologies®; Tyr 1349, #3121 – Cell Signaling®), anti-MET (3D4 - Life Technologies®, directed against kinase domain, used for WB,

(16) Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusionsOncogenesisJanuary 23, 2018Tamura R, Yoshihara K, Saito T, Ishimura R, Martínez-Ledesma JE, Xin H, Ishiguro T, Mori Y, Yamawaki K, Suda K, et al.

(17) A metabolic function of FGFR3-TACC3 gene fusions in cancerNatureJanuary 11, 2018Frattini V, Pagnotta SM, Tala, Fan JJ, Russo MV, Lee SB, Garofano L, Zhang J, Shi P, Lewis G, et al.

(18) MicroRNA-17-5p contributes to osteoarthritis progression by binding p62/SQSTM1Experimental and Therapeutic MedicineDecember 12, 2017Huihui Li, Daoyi Miao, Qi Zhu, Jianghua Huang, Guangxian Lu, Weiguo Xu

(19) Induction of Immune Surveillance of the Dysmorphogenic LensScientific reportsNovember 24, 2017Logan CM, Bowen CJ, Menko AS.

(20) RCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cellsAngiogenesisAugust 1, 2017Ahmad F. Alghanem, Emma L. Wilkinson, Maxine S. Emmett, Mohammad A. Aljasir, Katherine Holmes, Beverley A. Rothermel, Victoria A. Simms, Victoria L. Heath, Michael J. Crossphospho-AKT (S473, #4058), phospho-ERK1/2 (T202/Y204, #9101), VEGFR-2 (#2479), phospho-HGFR/c-Met (Y1349; #3121) transferrin receptor (TfR) (#13113) and GAPDH (#5174) were purchased from Cell Signalling Technology

Be the First to Write a Review!

Phospho-Met (Tyr1349) Antibody

Phospho-Met (Tyr1349) Antibody from Cell Signaling Technology

Description

Cell Signaling Technology

Citations (30)

Reviews

Phospho-Met (Tyr1349) Antibody from Cell Signaling Technology

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map